Jenburkt Pharmaceuticals LtdBSE: JENBURPH

Announcement under Regulation 30 (LODR)-Newspaper Publication

Nov 4, 2026 at 5:02 AM EST · Issued by Jenburkt Pharmaceuticals Ltd via BSE India

Filed with BSE · ISIN INE354A01013 · Nov 4, 2026 at 5:02 AM EST · 2 pages · English

On 6ix: 6ix.com/news/announcement-under-regulation-30-lodr-newspaper-publication-3707

Jenburkt Pharmaceuticals Ltd on 6ix

Earlier from Jenburkt Pharmaceuticals

Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2026.Oct 29
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Oct 12
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 12
Jenburkt Pharmaceuticals Ltd Press Release Sep 04 2026Sep 4
Jenburkt Pharmaceuticals Ltd Press Release Aug 07 2026Aug 7

Later from Jenburkt Pharmaceuticals

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 4

All Jenburkt Pharmaceuticals news releases

Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.

Follow Jenburkt Pharmaceuticals